Gimeracil is a pyridine derivative with antitumor activity. Gimeracil enhances the antitumor activity of fluoropyrimidines by competitively and reversibly inhibiting the enzyme dihydropyrimidine dehydrogenase causing decreased degradation of the fluoropyrimidines. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus).
Properties:
Density: 1.56 g/cm3
Melting Point: 274ºC
Boiling Point: 281.9ºC at 760 mmHg
Flash Point: 124.3ºC
Refractive Index: 1.617
Vapor Pressure: 0.000408mmHg at 25°C
Dehydrogenase Inhibitors Related Products:
Mycophenolate mofetil; AGI-5198; SW033291; Vidofludimus; AGI-6780; Devimistat (CPI-613); Mycophenolic acid; Trilostane; Tenovin-1; Teriflunomide; AG-636; AG-120 (racemic); Ivosidenib; Brequinar